This inventor holds 5 USPTO granted patents and 3 published patent applications and 1 EPO patent. Top assignees: Hyundai Autron Company Ltd., Cbs Bioscience, Co., Ltd, Hyundai Electronics Ind. Co., Ltd.. Active years: 2000-2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Gwacheon-si, KR (2016)
- Seoul, KR (2000 - 2018)
Company Filing History:
2 out of 147 
1 out of 2 
1 out of 99 
Years Active: 2000-2018
Title: Jin-Young Park: Innovator in Molecular Targeted Therapy and Vehicle Technology
Introduction
Jin-Young Park is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the fields of molecular targeted therapy and vehicle technology. With a total of five patents to his name, Park's work reflects his dedication to advancing medical and automotive innovations.
Latest Patents
One of Jin-Young Park's latest patents is an analytical method for increasing susceptibility of molecular targeted therapy in hepatocellular carcinoma. This method allows for the determination of whether a patient has susceptibility or resistance to sorafenib treatment by analyzing the mRNA expression of FGFR1 and other biomarkers. This innovation aims to enhance patient selection for effective treatment options.
Another notable patent is a shift control method and apparatus for vehicles. This invention involves determining whether a vehicle meets an Idle Stop and Go (ISG) learning condition and adjusting the oil pressure supplied to the transmission solenoid accordingly. This method helps reduce variations in shift time when restarting ISG vehicles, thereby improving overall vehicle performance.
Career Highlights
Jin-Young Park has worked with notable companies such as Hyundai Autron Company Ltd. and KT Corporation. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in technology.
Collaborations
Throughout his career, Park has collaborated with talented individuals, including Dong-Sik Ha and Hong-Koo Kang. These partnerships have fostered a creative environment that encourages the development of groundbreaking inventions.
Conclusion
Jin-Young Park's contributions to molecular targeted therapy and vehicle technology exemplify his innovative spirit and commitment to improving lives through technology. His patents reflect a deep understanding of complex challenges and a drive to find effective solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile